AI自动定量胸部CT COVID-19磨玻璃影可区分危重与非危重患者
回顾性分析50例实验室确诊COVID-19患者的胸部CT,用全自动AI软件定量肺内磨玻璃影,并与临床和实验室指标相关分析。磨玻璃影范围与ICU入住、ICU住院时长、死亡结局及住院时长相关,ICU组磨玻璃影评分12.50显著高于非ICU组4.96,提示AI定量或可作为无创预测临床病程的标记。
要点
- AI自动定量COVID-19磨玻璃影范围与ICU入住、住院时长、死亡结局相关。
- ICU组磨玻璃影评分12.50 vs 非ICU组4.96,差异有统计学意义。
- 磨玻璃影范围与中性粒细胞计数、LDH、肌钙蛋白、CRP相关。
关键影像表现/征象
- 胸部CT上COVID-19样磨玻璃影范围与ICU入住(R=0.74)、ICU住院时长(R=0.81)、死亡结局(R=0.56)和住院时长(R=0.33,p<0.05)相关(除标注外均p<0.001)。
- 磨玻璃影范围与中性粒细胞计数(R=0.60)、乳酸脱氢酶(R=0.60)、肌钙蛋白(R=0.55)和C反应蛋白(R=0.51)相关。
- ICU组与非ICU组差异(p<0.001)包括住院时长更长(24.04 vs. 10.92天)、磨玻璃影评分更高(12.50 vs. 4.96)及实验室改变更严重如C反应蛋白(11.64 vs. 5.07 mg/dl,p<0.01)。
临床应用与阅片要点
- AI自动定量磨玻璃影范围可用于辅助评估COVID-19患者病情严重程度,高评分提示更可能需ICU治疗。
- 磨玻璃影范围与炎症及心肌损伤标志物相关,可结合实验室指标综合判断临床病程。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the potential of a fully automatic artificial intelligence (AI)-driven computed tomography (CT) software prototype to quantify severity of COVID-19 infection on chest CT in relationship with clinical and laboratory data.
METHODS: We retrospectively analyzed 50 patients with laboratory confirmed COVID-19 infection who had received chest CT between March and July 2020. Pulmonary opacifications were automatically evaluated by an AI-driven software and correlated with clinical and laboratory parameters using Spearman-Rho and linear regression analysis. We divided the patients into sub cohorts with or without necessity of intensive care unit (ICU) treatment. Sub cohort differences were evaluated employing Wilcoxon-Mann-Whitney-Test.
RESULTS: We included 50 CT examinations (mean age, 57.24 years), of whom 24 (48%) had an ICU stay. Extent of COVID-19 like opacities on chest CT showed correlations (all p < 0.001 if not otherwise stated) with occurrence of ICU stay (R = 0.74), length of ICU stay (R = 0.81), lethal outcome (R = 0.56) and length of hospital stay (R = 0.33, p < 0.05). The opacities extent was correlated with laboratory parameters: neutrophil count (NEU) (R = 0.60), lactate dehydrogenase (LDH) (R = 0.60), troponin (TNTHS) (R = 0.55) and c-reactive protein (CRP) (R = 0.51). Differences (p < 0.001) between ICU group and non-ICU group concerned longer length of hospital stay (24.04 vs. 10.92 days), higher opacity score (12.50 vs. 4.96) and severity of laboratory data changes such as c-reactive protein (11.64 vs. 5.07 mg/dl, p < 0.01).
CONCLUSIONS: Automatically AI-driven quantification of opacities on chest CT correlates with laboratory and clinical data in patients with confirmed COVID-19 infection and may serve as non-invasive predictive marker for clinical course of COVID-19.
引用
- Mader C, Bernatz S, Michalik S, et al. Quantification of COVID-19 Opacities on Chest CT - Evaluation of a Fully Automatic AI-approach to Noninvasively Differentiate Critical Versus Noncritical Patients. Acad Radiol. 2021. PMID: 33741210. doi:10.1016/j.acra.2021.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。